A bone marrow exam revealed MDS with excess blasts (MDS-EB2, 14% blasts) with flow cytometry showing increased blasts positive for CD34, HLA-DR, and partially positive for CD117, CD38, CD13, and CD33 (Fig. 1). This evidence concerns the gene CD33 and myelodysplastic syndrome.